+++
title = "iCoreConnect Challenges NASDAQ Delisting Notice with Hearing Request"
date = "2025-02-26T18:00:18Z"
draft = false
summary = "iCoreConnect Inc. has filed a hearing request to challenge a potential delisting from NASDAQ, highlighting its commitment to resolving shareholders' equity concerns and maintaining its public trading status."
description = "iCoreConnect Inc. (NASDAQ: ICCT) takes action to address Nasdaq Delisting Notice, filing a Hearing Request. Shareholders and investors await the outcome as compliance concerns loom."
source_link = "https://www.newmediawire.com/news/icoreconnect-files-hearing-request-with-nasdaq-7079595"
enclosure = "https://cdn.newsramp.app/banners/technology-3.jpg"
article_id = 94444
feed_item_id = 11170
url = "/202502/94444-icoreconnect-challenges-nasdaq-delisting-notice-with-hearing-request"
qrcode = "https://cdn.newsramp.app/newmediawire/qrcode/252/26/fernQ98g.webp"
source = "NewMediaWire"
+++

<p>Cloud-based software provider iCoreConnect Inc. has taken a significant step to contest a potential delisting from the NASDAQ stock exchange by filing a hearing request on February 25, 2025. This action comes in response to a delisting notice received on February 18, 2025, which cited concerns regarding the company's shareholders' equity. By initiating this hearing process, iCoreConnect seeks to temporarily halt any further delisting actions by NASDAQ, with the possibility of securing an extension from the Panel post-hearing.</p><p>This move underscores iCoreConnect's determination to address the regulatory concerns head-on and preserve its status as a publicly traded entity. Specializing in cloud-based software solutions that enhance healthcare workflow productivity, the company plays a pivotal role in the SaaS sector. The outcome of this hearing could have far-reaching implications not only for iCoreConnect but also for its stakeholders and the broader healthcare technology industry.</p><p>The hearing request marks a pivotal moment for iCoreConnect as it endeavors to navigate through this regulatory challenge. The company's ability to maintain its NASDAQ listing is crucial for its continued growth and its capacity to deliver innovative technology solutions to the healthcare sector. Investors and industry analysts are keenly awaiting the hearing's results, as it will provide valuable insights into iCoreConnect's future trajectory and its standing in the competitive market landscape.</p>